{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T12:28:43Z","timestamp":1790252923783,"version":"4.1.0"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2013,5,17]],"date-time":"2013-05-17T00:00:00Z","timestamp":1368748800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Immunol"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1186\/1471-2172-14-23","type":"journal-article","created":{"date-parts":[[2013,5,17]],"date-time":"2013-05-17T08:14:47Z","timestamp":1368778487000},"source":"Crossref","is-referenced-by-count":21,"title":["Impact of hepatitis C virus co-infection on HIV patients before and after highly active antiretroviral therapy: an immunological and clinical chemistry observation, Addis Ababa, Ethiopia"],"prefix":"10.1186","volume":"14","author":[{"given":"Solomon","family":"Taye","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mekuria","family":"Lakew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,5,17]]},"reference":[{"issue":"3","key":"527_CR1","first-page":"273","volume":"53","author":"P Kedziora","year":"2005","unstructured":"Kedziora P, Figlerowicz M, Formanowicz P: Computational methods in diagnostics of chronic hepatitis C. Bull Pol Ac Tech. 2005, 53 (3): 273-281.","journal-title":"Bull Pol Ac Tech"},{"key":"527_CR2","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1186\/1756-0500-4-193","volume":"4","author":"A Addisu","year":"2011","unstructured":"Addisu A, Yayehyirad T, Zufan S, Techalew S: Prevalence and risk factors of Hepatitis C among individuals presenting to HIV testing centers, Hawassa city, Southern Ethiopia. BMC Research Notes, Short Report. 2011, 4: 193-10.1186\/1756-0500-4-193.","journal-title":"BMC Research Notes, Short Report"},{"issue":"76","key":"527_CR3","first-page":"11","volume":"79","author":"A Mohsen","year":"2003","unstructured":"Mohsen A, Easterbrook P: Hepatitis C testing in HIV infected patients. J Sex Trans Inf. 2003, 79 (76): 11-36.","journal-title":"J Sex Trans Inf"},{"issue":"2","key":"527_CR4","first-page":"137","volume":"54","author":"F Guo","year":"2010","unstructured":"Guo F, Wei L, Han Y: Impact of Hepatitis C Virus Coinfection on HAART in HIV-Infected Individuals: Multicentric Observation Cohort. J AIDS. 2010, 54 (2): 137-142.","journal-title":"J AIDS"},{"issue":"1","key":"527_CR5","first-page":"14","volume":"9","author":"R Chung","year":"2004","unstructured":"Chung R: Management of HIV\/HCV coinfection. The PRN notebook. 2004, 9 (1): 14-19. http:\/\/www.prn.org ,","journal-title":"The PRN notebook"},{"key":"527_CR6","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1001\/jama.283.1.74","volume":"284","author":"M Sulkowski","year":"2000","unstructured":"Sulkowski M, Thomas D, Chaisson R, Moore R: Drug-associated Liver Disease during HAART: impact of HCV Coinfection. JAMA. 2000, 284: 74-80.","journal-title":"JAMA"},{"key":"527_CR7","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1002\/jmv.10164","volume":"68","author":"A Workenesh","year":"2002","unstructured":"Workenesh A, Cutts F, Nokes J: Higher prevalence of anti-HCV antibodies among HIV-positive compared to HIV-negative inhabitants of Addis Ababa: results from a community based survey. J Med Virol. 2002, 68: 12-17. 10.1002\/jmv.10164.","journal-title":"J Med Virol"},{"key":"527_CR8","first-page":"16","volume":"9","author":"F Gatti","year":"2007","unstructured":"Gatti F, Nasta P, Matti A: Treating Hepatitis C Virus in HIV Patients: Are Side Effects a Real Obstacle?. AIDS Rev. 2007, 9: 16-24.","journal-title":"AIDS Rev"},{"issue":"22","key":"527_CR9","doi-asserted-by":"crossref","first-page":"109","DOI":"10.2807\/ese.13.22.18888-en","volume":"13","author":"C Larsen","year":"2008","unstructured":"Larsen C, Pialoux G, Salmon D: Prevalence of hepatitis C and hepatitis B infection in the HIV-infected population of France. Eurosurveillance. 2008, 13 (22): 109-112.","journal-title":"Eurosurveillance"},{"key":"527_CR10","doi-asserted-by":"publisher","first-page":"29","DOI":"10.7150\/ijms.3.29","volume":"3","author":"V Brass","year":"2006","unstructured":"Brass V, Moradpour D, Blum H: Molecular Virology of Hepatitis C Virus (HCV). Int J Med Sci. 2006, 3: 29-34.","journal-title":"Int J Med Sci"},{"issue":"93","key":"527_CR11","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1053\/jhep.2003.50103","volume":"37","author":"K Sugimoto","year":"2003","unstructured":"Sugimoto K, Stadanlick J, Ikeda F: Influence of Ethnicity in the Outcome of Hepatitis C Virus Infection and Cellular Immune Response. J Hepat. 2003, 37 (93): 590-599.","journal-title":"J Hepat"},{"key":"527_CR12","volume-title":"HIV and Hepatitis.com","author":"L Highleyman","year":"2008","unstructured":"Highleyman L: Does HIV-HCV Coinfection Increase the Risk of Liver Disease Progression and Worsen Clinical Outcomes?. HIV and Hepatitis.com. 2008"},{"key":"527_CR13","doi-asserted-by":"publisher","first-page":"447","DOI":"10.7326\/0003-4819-133-6-200009190-00013","volume":"133","author":"J DeSimone","year":"2000","unstructured":"DeSimone J, Pomerantz R, Babinchak T: Inflammatory Reactions in HIV-1 Infected Persons after Initiation of Highly Active Antiretroviral Therapy. Ann Intern Med. 2000, 133: 447-454. 10.7326\/0003-4819-133-6-200009190-00013.","journal-title":"Ann Intern Med"},{"issue":"1","key":"527_CR14","first-page":"51","volume":"17","author":"A Lawson","year":"2010","unstructured":"Lawson A: Hepatitis C, virus-infected patients with a persistently normal alanine aminotransferase: Do they exist and is this really a group with mild disease?. J Viral Hepat. 2010, 17 (1): 51-58.","journal-title":"J Viral Hepat"},{"key":"527_CR15","doi-asserted-by":"publisher","first-page":"1678","DOI":"10.1086\/379774","volume":"37","author":"N Marina","year":"2003","unstructured":"Marina N, Vincent S: How effective is HAART in HCV and HIV coinfection?. Clin Infect Dis. 2003, 37: 1678-1685. 10.1086\/379774.","journal-title":"Clin Infect Dis"}],"container-title":["BMC Immunology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2172-14-23.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2172-14-23\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2172-14-23.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,17]],"date-time":"2022-02-17T07:59:09Z","timestamp":1645084749000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcimmunol.biomedcentral.com\/articles\/10.1186\/1471-2172-14-23"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5,17]]},"references-count":15,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["527"],"URL":"https:\/\/doi.org\/10.1186\/1471-2172-14-23","relation":{},"ISSN":["1471-2172"],"issn-type":[{"value":"1471-2172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,5,17]]},"article-number":"23"}}